Upregulation of shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms

Brain Pathology

Volumn 25, Issue 2, 2015, Pages 146-156

  Hagel, Christian ^a   Krasemann, Susanne ^a   Löffler, Judith ^a   Püschel, Klaus ^a   Magnus, Tim ^a   Glatzel, Markus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CD77 Gb3; enterohemorrhagic Escherichia coli; hemolytic uremic syndrome; microglia; neuropathology; vasculature

Indexed keywords

ANGIOPOIETIN 1; CD34 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLOBOTRIAOSYLCERAMIDE; GLOBOTRIAOSYLCERAMIDE 3; HEMOSIDERIN; INTERLEUKIN 1BETA; LEUKOCYTE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE-ASSOCIATED PROTEIN 2C; PROTEIN ZO1; SHIGA TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VIMENTIN; VON WILLEBRAND FACTOR; CERAMIDE TRIHEXOSIDE;

AGED; ANGULAR GYRUS; ARTICLE; AUTOPSY; BRAIN LEVEL; BRAIN REGION; CEREBELLUM VERMIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORPORA MAMMILLARIA; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; FEMALE; FRONTAL CORTEX; FRONTAL OPERCULUM; GENE EXPRESSION; HEMISPHERE; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; MALE; MEDULLA OBLONGATA; MICROGLIA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PONS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TEMPORAL CORTEX; THALAMUS; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING; BRAIN; COGNITIVE DEFECT; ENCEPHALITIS; ESCHERICHIA COLI INFECTION; METABOLISM; MICROBIOLOGY; PATHOLOGY; ULTRASTRUCTURE; VASCULARIZATION;

AGED; AGED, 80 AND OVER; BRAIN; COGNITION DISORDERS; ENCEPHALITIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INTERLEUKIN-1BETA; MALE; TRIHEXOSYLCERAMIDES; UP-REGULATION;

EID: 84922759400     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12166     Document Type: Article

References (24)

1. Blackwell CC, Dundas S, James VS, Mackenzie DA, Braun JM, Alkout AM, et al (2002) Blood group and susceptibility to disease caused by Escherichia coli O157. J Infect Dis 185: 393-396.
2. Branch DR, (2010) Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol 17: 558-564.
3. Cilmi SA, Karalius BJ, Choy W, Smith RN, Butterton JR, (2006) Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli. J Infect Dis 194: 1135-1140.
4. Dinarello CA, (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201: 1355-1359.
5. Falguières T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, et al (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12: 2453-2468.
6. Fründt TW, Höpker W-W, Hagel C, Sperhake JP, Isenberg AH, Lüth S, et al (2013) EHEC-0104:H4-Ausbruch im Sommer 2011. Rechtsmedizin 23: 374-382.
7. Gallo EG, Gianantonio CA, (1995) Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome. Pediatr Nephrol 9: 117-119.
8. Khan F, Proulx F, Lingwood CA, (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int 75: 1209-1216.
9. Lingwood CA, Binnington B, Manis A, Branch DR, (2010) Globotriaosyl ceramide receptor function-where membrane structure and pathology intersect. FEBS Lett 584: 1879-1886.
10. Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, et al (2012) An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 55: 753-759.
11. Löbel U, Eckert B, Simova O, Meier-Cillien M, Kluge S, Gerloff C, et al (2014) Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4. Clin Neuroradiol 24: 111-119.
12. Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, et al (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135: 1850-1859.
13. Mayer CL, Leibowitz CS, Kurosawa S, Stearns-Kurosawa DJ, (2012) Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) 4: 1261-1287.
14. Merrill MJ, Oldfield EH, (2005) A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg 103: 853-868.
15. Mizuguchi M, Sugatani J, Maeda T, Momoi T, Arima K, Takashima S, et al (2001) Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2. Acta Neuropathol 102: 306-312.
16. Mukhopadhyay S, Linstedt AD, (2012) Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335: 332-335.
17. Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, et al (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5: 1218-1228.
18. Neri P, Tokoro S, Yokoyama S, Miura T, Murata T, Nishida Y, et al (2007) Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue: a novel class of Shiga toxin-neutralizing agent. Biol Pharm Bull 30: 1697-1701.
19. Rohde H, Qin J, Cui Y, Li D, Loman NJ, Hentschke M, et al (2011) Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N Engl J Med 365: 718-724.
20. Shimada O, Ishikawa H, Tosaka-Shimada H, Atsumi S, (1999) Exocytotic secretion of toxins from macrophages infected with Escherichia coli O157. Cell Struct Funct 24: 247-253.
21. Smith DC, Sillence DJ, Falguières T, Jarvis RM, Johannes L, Lord JM, et al (2006) The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell 17: 1375-1387.
22. Tesh VL, (2012) Activation of cell stress response pathways by Shiga toxins. Cell Microbiol 14: 1-9.
23. Tironi-Farinati C, Loidl CF, Boccoli J, Parma Y, Fernandez-Miyakawa ME, Goldstein J, (2010) Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol 222: 48-61.
24. Zampetti A, Gnarra M, Borsini W, Giurdanella F, Antuzzi D, Piras A, et al (2013) Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement. Cytokine 61: 933-939.